---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-006220"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T16:48:28.794873+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Iradimed Q1 record revenue $19.5M (+11% YoY); EPS $0.37 GAAP, $0.42 non-GAAP

## Summary
- Record Q1 revenue of $19.5M, up 11% YoY from $17.6M; GAAP diluted EPS $0.37 (+16% YoY).
- Non-GAAP diluted EPS $0.42 (+17% YoY); excludes $0.7M stock compensation net of tax.
- Declared regular quarterly cash dividend of $0.17/share, payable May 30, 2025 to holders of record May 20.
- Q2 2025 guidance: revenue $19.7-19.9M; GAAP EPS $0.37-0.40; non-GAAP EPS $0.41-0.44.
- Reaffirms FY 2025 guidance: revenue $78-82M; GAAP EPS $1.55-1.65; non-GAAP EPS $1.71-1.81.

## SEC filing metadata
- accession: 0001558370-25-006220
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837025006220/0001558370-25-006220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837025006220/irmd-20250505x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-006220
- JSON: https://secwatch.observer/filing/0001558370-25-006220.json
- Plain text: https://secwatch.observer/filing/0001558370-25-006220.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.